Millennium Management LLC grew its position in shares of Aemetis, Inc. (NASDAQ:AMTX) by 191.3% in the second quarter, HoldingsChannel reports. The firm owned 420,483 shares of the specialty chemicals company’s stock after buying an additional 276,119 shares during the quarter. Millennium Management LLC’s holdings in Aemetis were worth $4,697,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. UBS Group AG grew its position in shares of Aemetis by 109.9% during the first quarter. UBS Group AG now owns 2,084 shares of the specialty chemicals company’s stock valued at $51,000 after purchasing an additional 1,091 shares in the last quarter. BNP Paribas Arbitrage SA purchased a new position in shares of Aemetis during the second quarter valued at approximately $33,000. Royal Bank of Canada boosted its position in shares of Aemetis by 2,069.1% during the second quarter. Royal Bank of Canada now owns 7,592 shares of the specialty chemicals company’s stock valued at $85,000 after buying an additional 7,242 shares during the period. JPMorgan Chase & Co. purchased a new position in shares of Aemetis during the second quarter valued at approximately $100,000. Finally, Cubist Systematic Strategies LLC bought a new stake in shares of Aemetis during the first quarter valued at approximately $314,000. Hedge funds and other institutional investors own 47.48% of the company’s stock.
In other Aemetis news, Director John R. Block sold 14,511 shares of the company’s stock in a transaction on Thursday, September 16th. The shares were sold at an average price of $13.94, for a total value of $202,283.34. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Andrew B. Foster sold 8,548 shares of the company’s stock in a transaction dated Wednesday, September 15th. The stock was sold at an average price of $14.08, for a total transaction of $120,355.84. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 140,921 shares of company stock worth $2,561,450. 14.65% of the stock is owned by corporate insiders.
Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Thursday, November 11th. The specialty chemicals company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.25). During the same quarter in the prior year, the firm earned ($0.59) EPS. As a group, sell-side analysts forecast that Aemetis, Inc. will post -2.04 earnings per share for the current year.
AMTX has been the subject of a number of recent research reports. HC Wainwright reissued a “buy” rating on shares of Aemetis in a research note on Monday, August 16th. Credit Suisse Group reduced their price objective on shares of Aemetis from $40.00 to $31.00 and set an “outperform” rating for the company in a research note on Monday, August 23rd. Stifel Nicolaus reissued a “buy” rating and issued a $33.00 price objective (up previously from $31.00) on shares of Aemetis in a research note on Monday, August 23rd. Finally, Zacks Investment Research downgraded shares of Aemetis from a “hold” rating to a “sell” rating in a research note on Monday, November 15th. One analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $31.17.
Aemetis Company Profile
Aemetis, Inc is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota.
Featured Story: Non-Fungible Token (NFT)
Want to see what other hedge funds are holding AMTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aemetis, Inc. (NASDAQ:AMTX).
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.